Author

Jonathan Sabio

New York UniversityORCID 0009-0002-1138-7493Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Developmental Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:gene regulatory network inference· 3 Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

Dimitris G. PlacantonakisiD· 3 shared Sara HaddockiD· 3 shared Shuai WangiD· 3 shared Adler Guerrero· 2 shared Albert Jiang· 2 shared Aristotelis TsirigosiD· 2 shared Cathryn Lapierre· 2 shared Devin BreadyiD· 2 shared

Activity by Year

2023-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Dimitris G. PlacantonakisORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Developmental BiologybioRxivPreprintSep 11, 2026

A developmentally regulated long-range enhancer-promoter contact mediates human neural development

Devin Bready, Shuai Wang, Niklas Ravn-Boess…·Dimitris G. Placantonakis

The paper identifies a developmentally regulated long-range enhancer-promoter contact that is critical for SOX2 expression and neuroectodermal differentiation in human neural development.

DOI 10.64898/2025.12.01.691702

humanDNA methylation

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMay 15, 2026

Purinergic signaling promotes gliomagenesis through nuclear calcium transients

Shuai Wang, Jenna Richter, Claire Kim…·Dimitris G. Placantonakis

This study identifies purinergic signaling via P2RY1 receptors and nuclear calcium transients as a driver of glioblastoma tumorigenesis, with therapeutic potential through P2RY1 inhibition.

DOI 10.64898/2026.05.11.724407

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyCell ReportsPeer-reviewedNov 1, 2023

The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerability

Niklas Ravn-Boess, Nainita Roy, Takamitsu Hattori…·Dimitris G. Placantonakis

This study identifies CD97 as a targetable vulnerability in glioblastoma through its role in tumor metabolism and signaling, supported by transcriptomic, proteomic, and functional analyses.

28 citations

humanbulk RNA-seq

𝕏 PostBluesky